Oncology Xagena
Women who have ductal carcinoma in situ ( DCIS ) are very likely to develop invasive breast cancer if left untreated. The risk extends over more than forty years Invasive ductal carcinoma, unlike ...
An investigational new drug Sutent ( Sunitinib ) more than doubled survival and significantly reduced tumor growth and spread in patients with Imatinib-resistant gastrointestinal stromal tumors ( GIS ...
Zoledronic Acid ( Zometa ), an intravenous bisphosphonate, was shown to inhibit aromatase inhibitor-induced bone loss in postmenopausal women treated with Letrozole ( Femara ) in the adjuvant breast c ...
A study of Bevacizumab ( Avastin ) plus Paclitaxel chemotherapy in first-line metastatic breast cancer met its primary efficacy endpoint of improving progression-free survival, compared to chemothera ...
A joint interim analysis of two studies of Trastuzumab ( Herceptin ) in early-stage breast cancer showed that HER2-positive breast cancer patients receiving Herceptin plus chemotherapy had a 52 perce ...
The treatment with Letrozole ( Femara ) of postmenopausal women with early breast cancer prolonged disease-free survival by reducing the risk of recurrence an additional 19% over that offered by Tamox ...
Researchers at University of Texas Southwestern Medical Center, Dallas, showed that a monoclonal antibody, that binds anionic phospholipids on tumor blood vessels, significantly reduces breast cancer ...
A clinical trial demonstrated that the chemotherapy regimen of Doxorubicin plus Docetaxel ( Taxotere ), used to treat breast cancer, was associated with an increased risk of serious complications, res ...
Researchers at the University of Michigan Comprehensive Cancer Center found a new technique might allow women diagnosed with cancer the opportunity to have children when chemotherapy and radiation tr ...
A study, funded by the National Institutes of Health, found that women with breast cancer who engaged in an amount of physical activity equivalent to walking 1 or more hours per week had better surviv ...
Researchers at the Keck School of Medicine of the University of Southern California, Los Angeles, found that women using Ibuprofen every day for five years or longer were more than 50 percent more lik ...
Italian researchers found that high-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unl ...
A study, led by investigators at Meharry Medical College and the Vanderbilt-Ingram Cancer Center, suggests that women who exercise more and keep their weight under control may dramatically reduce thei ...
Researchers Mayo Clinic discovered a mechanism that blocks the bodys natural ability to reject breast cancer. They also described an experimental therapy to remove that block. The goal of the re ...
Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence. Women who are 20 to 25 percent over their ide ...
